focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,966.00
Bid: 2,967.00
Ask: 2,969.00
Change: 16.00 (0.54%)
Spread: 2.00 (0.067%)
Open: 2,966.00
High: 2,978.00
Low: 2,939.00
Prev. Close: 2,950.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on portfolio and Capital Markets Seminar

20 Sep 2023 07:00

RNS Number : 9802M
3i Group PLC
20 September 2023
 

 

Press release

20 September 2023

 

3i Group plc

Update on portfolio and Capital Markets Seminar

 

3i Group plc ("3i" or "the Group") will be holding a Capital Markets Seminar via webcast today, involving presentations on nexeye and European Bakery Group, two of our Private Equity investments, as well as on our in-house Private Equity Banking Team. In addition, Simon Borrows, our Chief Executive, will provide an update on the portfolio more broadly, the key elements of which are outlined below. The seminar will start at 14.00 and the joining details are provided at the end of this press release. The presentation materials and a recording of the webcast will also be made available on our website.

 

We have completed our September semi-annual portfolio company reviews for Private Equity and Infrastructure. Our investment portfolios continue to make good progress against a difficult macroeconomic backdrop. In our Private Equity portfolio, assets in the value-for-money consumer and private label, healthcare, speciality industrial and technology services sectors are generating resilient earnings growth and are showing positive momentum as we head into the second half of our financial year. Our travel related assets have seen a sustained increase in demand. Luqom and YDEON continue to face a challenging sales environment following the Covid lockdown period. Tato, Formel D and Wilson are also dealing with weaker end markets and the resulting reduction in customer demand. 3i's strong active asset management processes continue to be a key part of how we mitigate the impact of today's market challenges.

 

Action's impressive performance has continued with very strong sales and EBITDA growth. Year-to-date sales (at 17 September 2023) of €7.5 billion are now 31% ahead of the same period last year. LFL sales growth over the same period was 20%, driven primarily by high customer footfall. As previously indicated LFL performance comparisons will be more challenging for the remainder of the current calendar year. Action continues to attract significant new customer flow through very low prices and good product availability in store, with strong performance across all geographies and categories. We expect operating EBITDA for the 12 months to the end of P9 2023 to be circa €1,530 million compared to €1,036 million at the end of September 2022. Cash generation has continued to be strong, with cash balances at 17 September 2023 at €1,014 million. Action has now added 140 net new stores in the year to date and remains on track to add circa 300 stores in 2023.

 

 

A live webcast of the seminar will be available at 14.00. To register for the webcast, please visit https://www.3i.com/investor-relations/capital-markets-presentations/2023/

 

- Ends-

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXNNFFSDEFA
Date   Source Headline
5th Jan 20224:58 pmRNSDirector/PDMR Shareholding
4th Jan 20229:43 amRNSPortfolio Update
16th Dec 20217:00 amRNSDirector Declaration
14th Dec 20217:00 amRNSDirectorate Change
9th Dec 202110:57 amRNSBlock listing Interim Review
30th Nov 20213:53 pmRNSTotal Voting Rights
30th Nov 20213:52 pmRNSDirector/PDMR Shareholding
30th Nov 202111:53 amRNSDirector/PDMR Shareholding
11th Nov 202111:05 amRNSDirectorate Change
11th Nov 20219:52 amRNSDoc re. Half Yearly Report 2021
11th Nov 20217:02 amRNSGroup Finance Director succession
11th Nov 20217:00 amRNSResults for the six months to 30 September 2021
3rd Nov 20211:44 pmRNSHolding(s) in Company
2nd Nov 20217:30 amRNS3i portfolio company Action announces new CEO
29th Oct 20212:29 pmRNSTotal Voting Rights
29th Oct 20212:22 pmRNSDirector/PDMR Shareholding
1st Oct 202112:59 pmRNSDirector/PDMR Shareholding
1st Oct 202110:04 amRNSPortfolio Update
30th Sep 20214:16 pmRNSTotal Voting Rights
30th Sep 20214:15 pmRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSDirectorate Change
29th Sep 20212:25 pmRNSDirector/PDMR Shareholding
28th Sep 20219:27 amRNSDirector/PDMR Shareholding
27th Sep 20217:00 amRNSUpdate on portfolio and Capital Markets Seminar
21st Sep 202112:27 pmRNSDirector/PDMR Shareholding
31st Aug 20214:00 pmRNSTotal Voting Rights
31st Aug 20213:59 pmRNSDirector/PDMR Shareholding
10th Aug 202110:25 amRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSFY2022 Q1 performance update
1st Jul 20213:14 pmRNSDirector/PDMR Shareholding
1st Jul 20213:07 pmRNSDirector/PDMR Shareholding
1st Jul 202111:47 amRNSResult of AGM
1st Jul 202111:42 amRNSDoc re. AGM Resolutions
1st Jul 20219:59 amRNSPortfolio Update
30th Jun 20214:15 pmRNSDirector/PDMR Shareholding
30th Jun 20214:09 pmRNSTotal Voting Rights
30th Jun 20214:04 pmRNSDirector/PDMR Shareholding
29th Jun 20212:24 pmRNSDirector/PDMR Shareholding
29th Jun 20211:55 pmRNSDirector/PDMR Shareholding
10th Jun 202110:55 amRNSBlock listing Interim Review
8th Jun 20212:25 pmRNSDirector/PDMR Shareholding
4th Jun 20212:35 pmRNSDirector/PDMR Shareholding
3rd Jun 202112:12 pmRNSDirector/PDMR Shareholding
2nd Jun 20219:48 amRNSDTR 6.3.5
28th May 20215:05 pmRNSTotal Voting Rights
28th May 20215:01 pmRNSDirector/PDMR Shareholding
26th May 20213:16 pmRNSDoc re. 2021 Notice of AGM
19th May 202111:56 amRNSDoc re. 2021 Annual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.